Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2024-04-03 00:00:00 ET · period of report 2024-03-20 · accession 0001104659-24-043249 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-03 | 2024-04-02 | RYTM | German Christopher Paul | CAO, Corp. Ctrl | S - Sale+OE | $41.76 | -368 | 795 | -32% | -$15.4K |
| D | 2024-04-03 | 2024-03-20 | RYTM | German Christopher Paul | CAO, Corp. Ctrl | M - OptEx | — | +1,163 | 1,163 | New | — |
| D | 2024-04-03 | 2024-03-20 | RYTM | German Christopher Paul | CAO, Corp. Ctrl | M - OptEx | $0.00 | -1,163 | 3,487 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-02 | S | D | 368 | $41.76 | 795 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $41.55 to $41.76. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-03-20 | M | A | 1,163 | — | 1,163 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. |
| 3 | Derivative | Restricted Stock Units | 2024-03-20 | M | D | 1,163 | $0.00 | 3,487 | D | — · — to — | 1,163 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F4) The restricted stock units have vested or will vest as to 25% of the total shares on each of March 20, 2024, March 20, 2025, March 20, 2026 and March 20, 2027, subject to the Reporting Person's continued service on each such vesting date. The restricted stock units have no expiration date. |